Co-Authors
This is a "connection" page, showing publications co-authored by VINCENT TAM and Cole Hudson.
Connection Strength
4.785
-
Response to comments: renal protective effect of montelukast. J Infect Dis. 2025 Apr 03.
Score: 0.980
-
Mechanisms of gelofusine protection in an in vitro model of polymyxin B-associated renal injury. Am J Physiol Renal Physiol. 2024 Jul 01; 327(1):F137-F145.
Score: 0.924
-
Zileuton ameliorates aminoglycoside and polymyxin-associated acute kidney injury in an animal model. J Antimicrob Chemother. 2023 10 03; 78(10):2435-2441.
Score: 0.884
-
In vitro model to simulate multiple drugs with distinct elimination half-lives. Int J Antimicrob Agents. 2023 Oct; 62(4):106924.
Score: 0.869
-
Reduction of vancomycin-associated acute kidney injury with montelukast. J Infect Dis. 2025 Jan 15.
Score: 0.242
-
In vitro evaluation of using ceftazidime/avibactam against carbapenem-resistant Acinetobacter baumannii. J Glob Antimicrob Resist. 2024 Sep; 38:252-255.
Score: 0.233
-
Optimal ceftazidime/avibactam dosing exposure against KPC-producing Klebsiella pneumoniae. J Antimicrob Chemother. 2022 10 28; 77(11):3130-3137.
Score: 0.207
-
Hydrolytic activity of KPC-producing Klebsiella pneumoniae clinical isolates. J Chemother. 2022 09; 34(5):345-346.
Score: 0.194
-
Experimental Validation of a Mathematical Framework to Simulate Antibiotics with Distinct Half-Lives Concurrently in an In Vitro Model. Antibiotics (Basel). 2021 Oct 16; 10(10).
Score: 0.193
-
Rapid Design of Combination Antimicrobial Therapy against Acinetobacter baumannii. Comput Chem Eng. 2025 Jan; 192.
Score: 0.059